Notes archive.
Rekvina posts its first-ever revenue. The losses continue.
The nano-cap reported ₹126.54 lakhs in sales for FY26, its first commercial revenue, but stayed in the red with a net loss of ₹25.47 lakhs.
RPSG Ventures reports consolidated losses despite a solid standalone Q4
Audited results show a ₹169.71 cr standalone profit, but consolidated performance trails due to sports segment losses.
Allcargo Terminals profit diverges as consolidated earnings climb 46%
Consolidated net profit reached ₹44.21 crore while standalone earnings slid 25%. Founder Shashi Kiran Shetty joins as a non-executive director.
Allcargo Terminals profit diverges between standalone and consolidated results
Consolidated net profit climbed to ₹44.21 crore as the board moved rights issue funds into capacity expansion.
Wakefit flips from loss to ₹189 cr profit in FY26
Revenue reached ₹1,488.9 cr as the mattress and home furnishing brand turned its financial performance around.
Repco Home Finance profit flat as loan book hits ₹15,880 crore
Sanctions climbed 28% while bad loans dropped to 2.55%, providing a cleaner look at FY26 performance.
Rekvina Laboratories generates its first revenue as losses persist
The nano-cap recorded ₹126.54 lakh in FY26 revenue while continuing to post a net loss of ₹25.47 lakh.
Ganesha Ecosphere hits 105% capacity as Q4 profit climbs to ₹23.21 crore
The company pivots to brownfield expansion, abandoning its Odisha greenfield project in a search for scale.
India Tourism Development Corporation posts steady profit despite qualified audit
Board recommends ₹2.95 per share dividend as recurring governance and accounting gaps persist.
Hindustan Foods' press release repeats every number from the audited filing
Total income of ₹4,264.7 cr, PAT of ₹149 cr, and ₹200–220 cr FY27 guidance were all already disclosed.
Wakefit turns profitable, reporting ₹189.2 cr net profit for FY26
The home furnishings retailer moved from a ₹35 cr loss to a profit, while booking a deferred tax asset of ₹103.4 cr to signal future gains.
Elegant Marbles posts 20% revenue growth, but investment loss sinks net income
A ₹23.4 crore mark-to-market loss on investments turned the year's total income negative, overshadowing modest top-line growth.
Wheels India's latest transcript confirms prior guidance
The company's FY26 earnings transcript contains no new information beyond the May 15 call summary.
Ganesha Ecosphere profit tanks 63% as margins fail to recover
Operating revenue remains flat at ₹1,481.66 cr, but the firm pumped ₹410 cr into subsidiaries via preference shares.
Jamshri cuts its annual loss by 85% but equity stays negative
The nano-cap's net loss narrowed to ₹18.61 lacs from ₹123.80 lacs, but its negative net worth stands at ₹535.27 lacs.
Link Pharma Chem flips to profit as revenue ticks up 8%
A nano-cap with a ₹13 crore market cap posts a modest ₹7.69 lakh profit for FY26.
Axis Solutions revenue climbs 19% as net profit slips 17%
CFO Ninad Vora returns to his post as the board declares a 60 paise dividend following a mixed fiscal year.
Hindustan Foods bets ₹150 crore on new capacity after record year
Contract manufacturer hits ₹104 crore quarterly EBITDA record and sticks to its ₹200-220 crore FY27 profit target.
Tirupati Foam wants to reclassify three independent directors as promoters.
The board meeting on May 29 will consider a governance change that could alter the board's independence ratio, alongside approving annual results.
Autoriders International posts ₹9 cr profit but leaves a ₹3 cr loan at risk
Auditors warn that Autoriders has not provisioned for a loan made to a group company that has ceased to be a going concern.
Credo Brands revenue drops 4% as annual profits slide by 31%
Despite a tough year of margin compression, the company hiked dividends fourfold to ₹2.00 per share.
iSERA Lifesciences posts FY26 profit of ₹25.94 lakhs
The company reported its annual audited results, showing a strong finish in Q4 as it pivots into software and IT services.
Niraj Cement Structurals confirms FY26 results with audit caveats
The company’s latest filing reiterates previously disclosed financials while flagging ongoing regulatory and tax issues.
Dr. Agarwal's Health Care reports FY26 revenue of over ₹2,000 cr
The company confirms FY26 growth targets with plans to add 60 new facilities in FY27 at a cost of up to ₹400 cr.
Chemcon Speciality Chemicals profit drops 3.5% for FY26
A late fourth-quarter recovery softens full-year earnings pressure as the board approves a ₹6.50 dividend.